3652 results for «233»
3652 results
Diversity in coronary artery disease treatment
22 May 2026 – From EuroPCR 2026
Focusing on the diversity in coronary artery disease treatment, this session highlights challenges ranging from maintaining interventional cardiology services during conflict to the influence of comorbidities such as type 2 diabetes mellitus on prognosis and risk assessment. It also presents clinical outcomes related to stent thrombosis...
Left main PCI-complex procedures
22 May 2026 – From EuroPCR 2026
This session covers complex left main coronary artery PCI procedures that challenge standard algorithms. It includes tackling chronic total occlusions of the left main, managing spontaneous coronary artery dissection in patients on ECMO, handling stent dislodgement, and addressing complex trifurcation lesions, providing comprehensive insights into advanced...
The Physiology Course - Introduction
18 May 2026 – From EuroPCR 2026
The Physiology Course introduction welcomes participants and provides an overview of the importance of coronary physiology, outlining the program designed in collaboration with EuroPCR.
The microcirculation: the next frontier in coronary practice
18 May 2026 – From EuroPCR 2026
Delve into the complexities of coronary microcirculation and its clinical implications. This session highlighted advanced diagnostic techniques such as bolus and continuous thermodilution, the interpretation of microvascular resistance reserve, and practical guidance on establishing a high-impact ANOCA clinic to manage microvascular angina and coronary dysfunction.
Closing lectures
18 May 2026 – From EuroPCR 2026
This session presents comprehensive closing lectures focusing on the evolving understanding of coronary microvascular dysfunction, examining the balance between vulnerability and physiology, and outlining future priorities for next-generation cathlab practices. It concludes with a session evaluation and synthesis of key learnings to inform clinical practice.
The physiological mindset: foundations every modern operator must own
18 May 2026 – From EuroPCR 2026
This session delves into the fundamental principles governing coronary blood flow regulation, emphasizing coronary autoregulation and the influence of epicardial haemodynamics on vascular morphology. Participants deepen their understanding of coronary physiology beyond formulas, exploring the intersection of physiology and atherosclerosis.
Physiology in the real world: how to measure, when to trust it, what to do?
18 May 2026 – From EuroPCR 2026
This session provides comprehensive insights into coronary physiology assessment tools, emphasizing techniques for reliable haemodynamic measurements and exploring clinical considerations surrounding coronary spasms and myocardial bridges.
Once you find microvascular disease, what do you actually do?
18 May 2026 – From EuroPCR 2026
Addressing coronary microvascular disease requires a comprehensive understanding of current medical therapies and emerging interventions. This session reviews state-of-the-art pharmacological treatments, elucidates the mechanisms and clinical data surrounding the coronary sinus reducer (CSR), and offers critical discussion on its therapeutic role in microvascular dysfunction.
EuroPCR 2026 – Long-term mortality following revascularisation for left main disease
20 May 2026
Paris, France, 19−22 May 2026. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during EuroPCR 2026 and are set to impact practice worldwide. Among them is a meta-analysis of long-term data from 4 randomised trials investigating...
FAVOR III China: Angiographic quantitative flow ratio-guided coronary intervention - a multicentre, randomised, sham-controlled trial
04 Nov 2021
Nicola Ryan provides her take on this investigator initiated, multicentre, randomised, blinded, sham controlled trial compares clinical outcomes of QFR versus angiography guided strategies for the treatment of non-critical lesions in patients with stable or unstable angina or MI at least 72 hours prior to screening....
Author
Early intra-aortic balloon pump in heart failure complicated by cardiogenic shock: The Altshock-2 randomized clinical trial
31 Mar 2025
Mirvat Alasnag provides her take on the Altshock-2 randomized clinical trial which was presented by Alice Sacco at ACC.25 in Chicago.
Author
Percutaneous transseptal transcatheter mitral valve replacement using a dedicated balloon-expandable valve: 1-year outcomes from the ENCIRCLE trial using the SAPIEN M3
27 Oct 2025
Jonathan Curio provides his take on the ENCIRCLE Trial presented by David Daniels at TCT 2025 in San Francisco.
Author
